Breaking News

Dutch State Sells Intravacc B.V.

Intravacc is an established independent CDMO for infectious diseases and therapeutic vaccines.

The State of the Netherlands, the Dutch Ministry of Health, Welfare and Sport aims to sell 100% of the issued and outstanding shares in the capital of Intravacc B.V. through a controlled auction process. 
 
Intravacc is an established independent contract development and manufacturing organization (CDMO) for infectious diseases and therapeutic vaccines.

As a CDMO with many years of experience in the development and optimization of vaccines and vaccine technologies, Intravacc has transferred its technology world-wide for many vaccines, including polio, measles, DTP, Hib, and influenza.

Intravacc offers a wide range of expertise for independent vaccine development, from proof-of-concept to Phase I/II clinical studies for partners around the world, including universities, public health organizations, biotech, and pharmaceutical companies.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters